Workflow
ZYN
icon
Search documents
轻工制造行业事项点评:菲莫国际:提出三年规划,聚焦新烟成长
Xinda Securities· 2026-02-09 00:24
菲莫国际:提出三年规划,聚焦新烟成长 [Table_Industry] 轻工制造 [Table_ReportDate] 2026 年 02 月 08 日 证券研究报告 行业研究 [Table_ReportType] 行业事项点评 [Table_StockAndRank] 轻工制造 投资评级 看好 上次评级 看好 [Table_Author] 姜文镪 新消费行业首席分析师 执业编号:S1500524120004 邮箱:jiangwenqiang@cindasc.com 李晨 新消费行业分析师 执业编号:S1500525060001 邮箱:lichen1@cindasc.com 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦B 座 邮编:100031 [Table_Title] 菲莫国际:提出三年规划,聚焦新烟成长 [Table_ReportDate] 2026 年 02 月 08 日 本期内容提要: [Table_S [事件:菲莫国际发布 Table_Summary ummary] ] 2025 年报。25 年收入达 406.5 亿美元(同比+ ...
菲莫国际:提出三年规划,聚焦新烟成长
Xinda Securities· 2026-02-08 14:58
菲莫国际:提出三年规划,聚焦新烟成长 [Table_Industry] 轻工制造 [Table_ReportDate] 2026 年 02 月 08 日 证券研究报告 行业研究 [Table_ReportType] 行业事项点评 [Table_StockAndRank] 轻工制造 投资评级 看好 上次评级 看好 [Table_Author] 姜文镪 新消费行业首席分析师 执业编号:S1500524120004 邮箱:jiangwenqiang@cindasc.com 李晨 新消费行业分析师 执业编号:S1500525060001 邮箱:lichen1@cindasc.com 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦B 座 邮编:100031 [Table_Title] 菲莫国际:提出三年规划,聚焦新烟成长 [Table_ReportDate] 2026 年 02 月 08 日 HNB 全球份额维持高位,日本竞争加剧。公司全年 HNB 销量达 1551 亿 支(同比+11.0%),全球市占率约 76%(倒算全球行业规模 25 年超 200 ...
Philip Morris International Q4 Earnings Call Highlights
Yahoo Finance· 2026-02-07 04:07
CFO Emmanuel Babeau said organic net revenue increased 6.5% in 2025, or 7.9% excluding what he described as a “technical Indonesia impact.” Organic operating income rose 10.6% with 140 basis points of organic margin expansion. In dollar terms, adjusted operating income grew 11.8% to $16.4 billion, and adjusted diluted EPS rose 14.2% at constant currency and 15% in dollar terms to $7.54. Babeau noted EPS landed at the high end of the company’s prior guidance range despite a lower-than-expected currency tailw ...
Philip Morris (PM) Q4 2025 Earnings Transcript
Yahoo Finance· 2026-02-06 15:42
We accomplished this through strong pricing, portfolio resilience, and disciplined execution, with Marlborough reaching a historic high share. Managing this business responsibly enables us to invest boldly in better alternatives and sustain our smoke-free momentum. Together, these factors enabled us to deliver 15% adjusted diluted EPS growth in dollar terms, the strongest growth since 2011, excluding the pandemic recovery year of 2021. This reflects currency-neutral growth of 14% well above our expectations ...
PMI(PM) - 2025 Q4 - Earnings Call Transcript
2026-02-06 15:02
Philip Morris International (NYSE:PM) Q4 2025 Earnings call February 06, 2026 09:00 AM ET Company ParticipantsEmmanuel Babeau - CFOEric Serotta - Executive Director for US Beverages, Tobacco, and Household ProductsJacek Olczak - Group CEOJames Bushnell - VP of Investor Relations and Financial CommunicationConference Call ParticipantsBonnie Herzog - Managing Director and Veteran AnalystDamian McNeela - Director and Senior Analyst of Consumer StaplesFaham Baig - Global Tobacco Analyst and Executive DirectorGe ...
PMI(PM) - 2025 Q4 - Earnings Call Transcript
2026-02-06 15:02
Philip Morris International (NYSE:PM) Q4 2025 Earnings call February 06, 2026 09:00 AM ET Company ParticipantsEmmanuel Babeau - CFOJacek Olczak - Group CEOJames Bushnell - VP of Investor Relations and Financial CommunicationConference Call ParticipantsGerald Pascarelli - Senior Analyst of Beverages, Tobacco, and CannabisMatt Smith - Senior Analyst of Consumer StaplesOperatorday and thank you for standing by. Welcome to the Philip Morris International, Inc., 2025 fourth quarter results conference call. At th ...
PMI(PM) - 2025 Q4 - Earnings Call Transcript
2026-02-06 15:00
Financial Data and Key Metrics Changes - In 2025, total net revenues exceeded $40 billion, with 41.5% or nearly $17 billion generated from smoke-free products [8][11] - Adjusted diluted EPS grew by 15% in dollar terms, marking the strongest growth since 2011, excluding the pandemic recovery year of 2021 [5][11] - Organic top-line growth was +6.5%, with adjusted operating income growth at +10.6%, reflecting +140 basis points of organic margin expansion [11][12] Business Line Data and Key Metrics Changes - Smoke-free product volumes grew by 12.8%, with organic smoke-free gross profit growth of 18.7% [3][12] - IQOS shipments grew by approximately 11%, with a notable acceleration in the fourth quarter [3][15] - ZYN shipments in the U.S. increased by 37%, contributing significantly to smoke-free product growth [5][14] Market Data and Key Metrics Changes - The international business generated the majority of total PMI organic net revenue growth, with smoke-free products leading the way [5][19] - In Japan, the heat-not-burn category surpassed 50% of total industry volumes, driven by IQOS [25][26] - The U.S. market for nicotine pouches saw ZYN capturing around 50% of category growth, with a volume share of 61.5% [30][22] Company Strategy and Development Direction - The company continues to focus on a multi-category strategy, expanding its smoke-free product offerings and geographic reach [4][9] - There is a strong emphasis on innovation and digitalization to support long-term growth [9][43] - The company targets a leverage ratio of close to 2x by the end of 2026, indicating a focus on financial flexibility and shareholder returns [7][44] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving strong growth despite transitory headwinds, with a forecast of 5%-7% organic net revenue growth for 2026 [36][37] - The company anticipates continued strong cash generation, with operating cash flow projected at around $13.5 billion [38][43] - Management highlighted the importance of navigating regulatory environments and enhancing brand equity for future growth [32][33] Other Important Information - The company achieved a historic high share for Marlboro, reaching 11% of the international category, excluding China [34][5] - The number of legal-age consumers of smoke-free products reached an estimated 43.5 million, reflecting broad-based growth across categories [20][19] - The company is committed to delivering superior shareholder value, with a target dividend payout ratio of around 75% of adjusted diluted EPS [44][45] Q&A Session Summary Question: Can you expand on the reacceleration in smoke-free volume growth compared to the 2026 growth guidance? - Management indicated that the acceleration is expected due to tax changes in Japan and competitive dynamics in the U.S. market [49][50] Question: How are you thinking in terms of IQOS, HTU shipments, and IMS for 2026? - Management noted that while Japan faces challenges, other markets like Italy and Germany are showing strong growth, contributing positively to IQOS's outlook [58][62] Question: What are the key growth drivers for the upcoming year? - Management emphasized the importance of ZYN and IQOS, along with ongoing investments in marketing and innovation, as key drivers for growth [72][75]
PMI(PM) - 2025 Q4 - Earnings Call Presentation
2026-02-06 14:00
2025 Fourth-Quarter and Full-Year Results February 6, 2026 Introduction • A glossary of terms as well as adjustments, other calculations and reconciliations to the most directly comparable U.S. GAAP measures for non-GAAP financial measures cited in this presentation are available in Exhibit 99.2 to the company's Form 8-K dated February 6, 2026 and on our Investor Relations website with additional non- GAAP reconciliations available at the end of this presentation 2 Forward-Looking and Cautionary Statements ...
Should Philip Morris Stock Be in Your Portfolio Ahead of Q4 Earnings?
ZACKS· 2026-02-03 16:05
Core Insights - Philip Morris International Inc. (PM) is expected to show growth in both revenue and earnings for Q4 2025, with revenue estimates at approximately $10.4 billion, reflecting a 7.3% increase year-over-year [1][9] - The earnings consensus remains steady at $1.67 per share, indicating a 7.7% increase from the previous year [2][9] Revenue and Earnings Performance - The anticipated revenue growth is supported by the company's shift towards a smoke-free product portfolio, which accounted for over 42% of gross profit in Q3 2025, driven by strong sales of IQOS, ZYN, and VEEV [3][9] - Smoke-free shipment volumes rose by 16.6%, and organic smoke-free revenues increased by 13.9%, indicating a favorable product mix and pricing strategy [4] Margin and Profitability - Pricing discipline and cost efficiencies have been significant contributors to margin expansion, with notable adjusted operating margin growth in Q3, supported by strong gross margins across both smoke-free and combustible categories [5] - Ongoing productivity initiatives and benefits from smoke-free growth are expected to continue supporting profitability, despite high commercial investments [5] Challenges and Headwinds - The company faces challenges from declining combustible cigarette volumes and foreign exchange volatility, with cigarette shipment volumes decreasing at a low-single-digit rate in Q3 [6] - These structural industry pressures are likely to persist into Q4, potentially impacting overall performance [6] Earnings Prediction Model - The current earnings prediction model does not indicate a strong likelihood of an earnings beat for Philip Morris, with an Earnings ESP of 0.00% and a Zacks Rank of 3 [7]
Altria or Philip Morris: Which Stock Looks Stronger in Today's Market?
ZACKS· 2026-01-30 16:40
Key Takeaways MO generated over $11B in 2025 in smokeable OI as pricing power offset a roughly 9.5% volume decline.PM's smoke-free products made up 41% of net revenues in Q3 2025, with shipments up 16.6%.PM's IQOS, ZYN and VEEV drove record smoke-free gross profit of $3.1B amid global adoption gains.For investors evaluating the tobacco sector, the decision often narrows to two industry leaders: Altria Group, Inc. (MO) and Philip Morris International Inc. (PM) . Although both companies derive significant rev ...